Stocks Shares Quotes Real time Price Nasdaq Dow Money NYSE AMEX Nasdaq CME CBOT NYBOT NYMEX COMEX Broker:Dailystocks.com
DailyStocks.com
 
What's New
Help
FAQ
Log In
Home Quotes/Data/Charts RT Streamer Investors Business Daily Ticker-based Links Tools RT Insiders RT News Extended Hours
Expert Advice OTCBB Books News/Edtrl Guides Reports Charts Buy/Sell Indicators About
Nanotech Videos Ratings/ModelFolio Value Investing Daytrading/TA Analysis Education Glossary Newsletters Real-time ECN
   No. 1 in ticker-based links

Sign up
Log In
Forgot Password
Free Wi-Fi Report
Free Nanotechnology Report
Watch List
MyDailyStocks
Sign up for our newsletters:
Actionable Ideas Newsletter
InsideCurve, which tracks Insider purchases.
Your Email:

Free VectorVest
  
Investors Business Daily

EXCLUSIVE DEALS
WallStreet Top100

RESEARCH
Stock Search Engine
Fund Search Engine

THE GUIDE
Daily Market Links
Daily Stocks Guide

RESEARCH REPORTS

AFFILIATES
Sample Call
Sign up
Modify

CONTACT US
Feedback
FAQ
Email a friend

SITE MAP

OLD SITE


Enter Ticker symbol?

Links: Quote | Chart | Opinion | Profile |
Select:
AGENUS INC - Fundamental Profile
Company Information
Ticker Symbol: AGEN
Exchange: NASD
Contact Info: 162 FIFTH AVENUE SUITE 900
NEW YORK NY 10010
212-994-8200
CEO/President: Garo H. Armen
Industry,Sector,
Index:
SIC: 2836, Medical - Biomedical
Description: Agenus Inc., formerly known as Antigenics Inc., is engaged in the discovery, development and commercialization of immunotherapeutics for the treatment of life threatening and chronic medical conditions. Immunotherapeutics are drugs that work by modulating the immune system to fight diseases. The Company's product line includes Oncophage vaccine, a patient-specific therapeutic cancer vaccine. The Company is also developing Prophage, patient-specific therapeutic cancer vaccine; QS-21, vaccine adjuvant; and HerpV, a polyvalent off-the-shelf therapeutic heat shock protein-based vaccine for treatment of genital herpes which are all in the clinical testing stages. Agenus Inc. is headquartered in Lexington, Massachusetts.

Share Information
Market Value, $K: 149,840 Shares Outstanding, K: 35,470
% Held by Insiders: 7.30% % Institutional Shareholders: 15.75%
Last Quarter Sales, $M: 0.39 Last Quarter Net Income, $M: -5.78
Last Quarter EPS: -0.16 P/E Ratio: 0.00
Annual EPS, $: -1.15 Most Recent Earnings, $:
Annual Dividend Rate, $: 0 Most Recent Dividend:
Annual Dividend Yield, %: 0% Most Recent Split: 1-6 on 10/03/11


Fundamental information provided by Zacks Investment Research, Inc. Zacks does not represent, warrant, or guarantee completeness, accuracy or timeliness of its data, and shall have no liability of any kind whatsoever to any party on account of any incompleteness of, inaccuracies in or untimeliness of the Zacks content provided hereunder, or for any delay in reporting such data. Zacks expressly disclaims all warranties of fitness of the Zacks content or computations and analyses thereof for a particular purpose or use.

Enter Symbol:    
Quote Chart Opinion Profile
Data provided by ddfplus and subject to terms of use. Copyright © 1995 - 2014 Barchart.com Inc. User agreement applies.

All Equities and Futures data is delayed according to exchange rules.
NYSE, AMEX and Nasdaq 15 minutes. Futures exchanges 10 minutes.


COPYRIGHTę 2001 DailyStocks. All Rights Reserved. Privacy Policy.